RAD54L mutation	Prostate Cancer	RAD54L mutation	Prostate Cancer	olaparib Sensitive: A2 - Guideline olaparib Sensitive : A2	olaparib Sensitive: A2 - Guideline olaparib Sensitive : A2
RAD54L mutation	Small Cell Lung Cancer	RAD54L mutation	Small Cell Lung Cancer	olaparib Sensitive: C2 – Inclusion Criteria olaparib Sensitive : C2	olaparib Sensitive: C2 – Inclusion Criteria olaparib Sensitive : C2
RAD54L mutation	HER2 Negative Breast Cancer	RAD54L mutation	HER2 Negative Breast Cancer	durvalumab Sensitive: C2 – Inclusion Criteria durvalumab Sensitive : C2	durvalumab Sensitive: C2 – Inclusion Criteria durvalumab Sensitive : C2
RAD54L underexpression	Soft Tissue Sarcoma	RAD54L underexpression	Soft Tissue Sarcoma	olaparib Sensitive: C3 – Early Trials olaparib Sensitive : C3	olaparib Sensitive: C3 – Early Trials olaparib Sensitive : C3

RAD54L (DNA Repair And Recombination Protein RAD54)

Associations(4)